News for Afya Limited (AFYA)

Afya Limited (AFYA) schedules its Annual General Meeting (AGM) for June 24, 2025. Shareholders can join virtually or in person to vote on key resolution

Notice is hereby given that an Annual General Meeting of the Company (the "AGM") will be held at the offices of Afya Participações S.A., Alameda Oscar Niemey

Afya Limited (Nasdaq: AFYA; B3: A2FY34) (”œAfya” or the ”œCompany”), the leading medical education group and medical practice solutions provider in Brazi

Afya Limited (NASDAQ:AFYA) Q1 2025 Earnings Conference Call May 8, 2025 5:00 PM ETCompany ParticipantsVirgilio Gibbon - Chief Executive OfficerLuis Andre...

Afya Limited (Nasdaq: AFYA; B3: A2FY34) (”œAfya” or the ”œCompany”), the leading medical education group and medical practice solutions provider in Brazi

Afya Limited (AFYA) reported a 23.4% YoY increase in first-quarter 2025 net income, amounting to R$257.0 million. Net revenue rose by 16.4% YoY to R$936

Baron Global Advantage Fund declined during the first quarter of 2025, underperforming its benchmark, the MSCI ACWI Index.

Afya (AFYA) delivered earnings and revenue surprises of 5.88% and 3.38%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Afya Limited (Nasdaq: AFYA; B3: A2FY34) (”œAfya” or the ”œCompany”), the leading medical education group and medical practice solutions provider in Brazi

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please ...

2024 was a forgettable year for White Brook Capital’s middle capitalization focused fund but our fortunes appear to have reversed in 2025. Click here to read more.

AFYA has announced a share purchase agreement to acquire 100% of FUNIC.

U.S. stock futures were mixed this morning, with the Dow futures falling around 0.1% on Monday. Shares of Zscaler Inc ZS fell sharply in today's pre-market tra...

Afya's strong 3Q24 results show growth in revenue and net income, making it an attractive investment opportunity with a P/E of 11x. Read more here.

Investors need to pay close attention to AFYA stock based on the movements in the options market lately.

Afya (AFYA) delivered earnings and revenue surprises of -11.11% and 3.55%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

Afya Limited to Report Third Quarter and Nine Months 2024 Financial Results on November 13th

Investors need to pay close attention to AFYA stock based on the movements in the options market lately.

Afya Assumes a Voluntary Commitment to Free Health Consultations